Tuesday, 14 January 2020

Veterinary Pain Management Market- Global Trends and Forecast to 2023


Market Highlights:
Veterinary Pain Management Market is growing rapidly and pervasively mainly due to the spreading awareness towards animal care. People are generally compassionate towards their pets, and they are increasingly becoming aware of animal physiology and psychology and the pain they go through during sickness, injuries, recoveries and after effects of the diseases. Besides, factors such as the increasing number of pet owners and the strengthening bond between owners and their animal companions escalate the market on the global heights.



Acknowledging the rapid expansions, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global veterinary pain management market will reach significant growth heights by 2023 registering 8.2% CAGR during the review period (2018 – 2023).
Additional factors substantiating the market growth include the rising per capita income that is leading to increasing the pet adoptions and the trend of nuclear families. Increased awareness concerning animal cruelty is influencing people’s ideologies and knowledge about animals.
Moreover, developments in animal health medicines and vaccines, along with the increased medical treatments are fostering the market growth of veterinary pain management market. Increased R&D expenditure to bring innovations in the products, and development of better and effective veterinary pharmaceuticals and vaccines, etc. are contributing to the market growth.
Improving economic conditions worldwide foster market growth, enabling access to the quality of life, increasing consumers’ buying power, and availing cost-effective veterinary healthcare.
On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-being and the rising cost of pet care, etc. are expected to impede the market growth. Also, unavailability of skilled doctors is a major restraint the market is confronting with.  Nevertheless, technological advancement, increasing number of ambulatory services coupled with the government and public organizations initiatives like PETA, working towards animal rights and liberation are expected to support market growth.

Veterinary Pain Management Market   - Segmentations
MRFR has segmented the analysis into seven key dynamics for better understanding: -

By Drug Type: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Local Anesthetics, Α2-Adrenergic Agonists, Muscle Relaxants, Sedatives, and Corticosteroids among others.
By Devices: Laser Therapy Devices and Electromagnetic Therapy Devices among others.
By Route of Administration: Oral, Parenteral, and Topical among others. 
By Animal Type: Companion Animals, Livestock, Research Animals, Aquatic Animals, Zoo Animals, and Exotic Animals among others.
By Application: Joint Pain, Postoperative Pain, and Cancer among others.
By End-user: Veterinary Hospitals & Clinics, Research Institutes & Universities, and Laboratories among others.                                                                                                                  
By Regions:  Europe, North America, APAC and the Rest-of-the-World.

Veterinary Pain Management Market   - Geographical Analysis
The North American region accounts for the leading market for veterinary pain management majorly due to the availability of a range of animal care products, emphasis on animal health, and stringent government regulations.  Also, technological innovations in the field of veterinary surgical instruments are acting as a tailwind pushing up the market growth in the region. 

Additional factors such as growing insurance coverage schemes are expected to push the growth of the veterinary pain management market in the region. Moreover, the increasing number of pets and a large patients’ pool, contribute to the growth of the regional market, demanding various treatment procedures and surgeries.
Countries such as Canada and the US are focusing on exporting surgical equipment and surgical suturing material across the world, which, in turn, is increasing the size of the market in this region. Besides, the growing number of veterinary hospitals fuel market growth.
The Veterinary Pain Management Market in the European region stands the second position in terms of the market size, owing to the increasing pet ownership fuelled by the tax benefits granted by the government.  Increase in animal diseases has led to an increasing number of surgeries and veterinary healthcare organizations. European countries like Germany, France, and the U.K, backed by the significant expenditures in the field of manufacturing of veterinary medical and surgical devices, majorly contributes to the growth of the regional market.
The Asia Pacific region is emerging as a promising market for companion veterinary pain management. China among other APAC dominates the regional market whereas, India accounts for the fastest growing market, followed by Australia and Japan.  Factors such as the presence of a large patient’s pool, increasing awareness towards animal health, and the improving economy are few of the driving forces pushing up the market in the region.
Veterinary Pain Management Market   - Competitive Landscape
The fiercely competitive veterinary pain management market appears to be fragmented due to many players forming a competitive landscape. Mergers & acquisitions, innovations, and Brand reinforcement remain the popular trends for the market players. Acquisitions of local manufactures by multinational companies are changing the market structure, increasing the profit of the company by reducing the competition significantly.

Key Players:
Some of the players leading the market include Zoetis, Boehringer Ingelheim, Chanelle, Ceva Santé Animale, Dechra Pharmaceuticals, Norbrook Laboratories, Merck Animal Health, Elanco, Assisi Animal Health, Bayer, and Vetoquinol.

Industry/ Innovation/ Related News:

November 08, 2018 – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for large animal healthcare products, announced the launch of its rebranded product line - EQUISTRO®. The rebranding includes new packaging for products and others. All EQUISTRO products are now available in veterinary clinics and in retail stores that sell feed, farm supplies, horse tack, and equine products. The rebranding strategy helps to expand the products available for performance horses through Vetoquinol.



About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312

Barotrauma Market Development History, Current Analysis and Estimated Forecast to 2023

Barotrauma Market Highlights

Owing to the increasing cases of ear barotrauma, technological advancements, increasing healthcare expenditure, unmet medical needs, patent expiration of blockbuster drugs, enhancing regulatory framework, increasing government assistance, and rising funding and reimbursement, the barotrauma market has evolved significantly.
However, huge capital investments with low-profit margins, strict FDA regulations, and poor healthcare system in the low and middle-income countries are likely to hamper the growth of the barotrauma market over the forecast period.
It is estimated that the Barotrauma Market is expected to have a CAGR of 6.5% during the forecast period of 2017–2023.
Regional Analysis
The Americas dominates the barotrauma market owing to the increasing prevalence of ear barotrauma and high healthcare expenditure.
Europe holds the second position in the barotrauma market. The financial support provided by the government towards R&D and technological advancements are expected to drive the European barotrauma market. The increasing healthcare expenditure is also boosting the European barotrauma market.


According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014, i.e., EUR 321 billion which is further followed by France with EUR 237 billion and United Kingdom with EUR 223 billion. In 2016, the R&D expenditure in the pharmaceutical industry was EUR 35000 million, suggested by the European Federation of Pharmaceutical Industries and Association.
Asia Pacific is the fastest growing barotrauma market owing to a huge patient pool and development in the pharmaceutical sector. Healthcare expenditure is found to be boosting in various regions of Asia Pacific. As per the data suggested by the Australian Institute of Health and Welfare during the year 2015–2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014–2015.
The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.
Segmentation
The global barotrauma market is segmented by type, diagnosis, treatment, and end-user.
On the basis of type, the barotrauma market is classified as ear barotrauma, sinus barotrauma, and pulmonary (lung) barotrauma.
On the basis of diagnosis, the barotrauma market is classified as otoscopy, X-ray, Computed Tomography (CT) scan, pulmonary function test, lung perfusion scan, Magnetic Resonance Imaging (MRI), pulse oximetry, and others.
On the basis of treatment, the barotrauma market is classified as pressure relief, medications, surgery, oxygen treatment, recompression therapy, and others. The medications segment is further classified as decongestant nasal sprays, oral decongestants, oral antihistamines, painkillers, antibiotics, and others. The surgery segment is further classified as Functional Endoscopic Sinus Surgery (FESS), tympanostomy, Single Laparoscopic Incision Transabdominal (SLIT), and others.
On the basis of end-user, the barotrauma market is segmented into hospitals and clinics, trauma centers, pharmaceutical companies, medical device companies, academic and research institutes, and others.
Key Players
Some of the key players in the global barotrauma market are 3M, Accurate Surgical & Scientific Instruments Corporation, AptarGroup, AstraZeneca plc., Atos Medical, CellScope, Entellus Medical Inc., GlaxoSmithKline plc, HEINE, Inventis, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Olympus Corporation, Pfizer, Inc., Cipla Ltd., Mylan N.V., Preceptis Medical, Rudolf Riester GmbH, Shanghai Yuejin, SinuSys Corporation, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., Sklar Surgical Instruments, Smith & Nephew Plc, Valeant pharmaceuticals International Inc., Hill-Rom, and others.
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Treatment Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Barotrauma Market, By Type
6.1 Introduction
6.2 Ear Barotrauma
6.2.1 Market Estimates & Forecast, 2017–2023
6.3 Sinus Barotrauma
6.3.1 Market Estimates & Forecast, 2017–2023
6.4 Pulmonary (Lung) Barotrauma
6.4.1 Market Estimates & Forecast, 2017–2023
Chapter 7. Global Barotrauma Market, By Diagnosis
7.1 Introduction
7.2 Otoscopy
7.2.1 Market Estimates & Forecast, 2017–2023
7.3 X-Ray
7.3.1 Market Estimates & Forecast, 2017–2023
7.4 Computed Tomography (CT) Scan
7.4.1 Market Estimates & Forecast, 2017–2023
7.5 Pulmonary Function Test
7.5.1 Market Estimates & Forecast, 2017–2023
7.6 Lung Perfusion Scan
7.6.1 Market Estimates & Forecast, 2017–2023
7.7 Computed Tomography (CT) Scan
7.7.1 Market Estimates & Forecast, 2017–2023
7.8 Pulmonary Function Test
7.8.1 Market Estimates & Forecast, 2017–2023
7.9 Lung Perfusion Scan
7.9.1 Market Estimates & Forecast, 2017–2023
Chapter 8. Global Barotrauma Market, By Treatment
8.1 Introduction
8.2 Pressure Relief
8.2.1 Market Estimates & Forecast, 2017–2023
8.3 Medications
8.3.1 Market Estimates & Forecast, 2017–2023
8.4 Surgery
8.4.1 Market Estimates & Forecast, 2017–2023
8.5 Oxygen Treatment
8.5.1 Market Estimates & Forecast, 2017–2023
8.6 Recompression Therapy
8.6.1 Market Estimates & Forecast, 2017–2023
8.7 Others
8.7.1 Market Estimates & Forecast, 2017–2023
Chapter 9. Global Barotrauma Market, By End-User
9.1 Introduction
9.2 Hospitals & Clinics
9.2.1 Market Estimates & Forecast, 2017–2023
9.3 Trauma Centers
9.3.1 Market Estimates & Forecast, 2017–2023
9.4 Pharmaceutical Companies
9.4.1 Market Estimates & Forecast, 2017–2023
9.5 Medical Device Companies
9.5.1 Market Estimates & Forecast, 2017–2023
9.6 Academic And Research Institutes
9.6.1 Market Estimates & Forecast, 2017–2023
9.7 Others
9.7.1 Market Estimates & Forecast, 2017–2023 


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312

Discography Market is set to grow by 8.20% CAGR by 2023


Market Highlights
Growing geriatric population resulting in the increasing prevalence of degenerative disc disease, increasing per capita healthcare expenditure and rising investments in research and development processes is estimated to drive the market during the forecast period. However, factors such as high procedural cost, complications in the operations, lack of awareness and low per capita healthcare expenditure in the developing countries are restraining the market growth.
The global discography market is expected to grow at an approximate CAGR of 8.20% during the forecast period.
Segmentation
The global Discography Market is segmented on the basis of type, component, application, indication, and end user. On the basis of the type, the market is segmented into lumbar discography, cervical discography, thoracic discography, and others. On the basis of the component, the market is categorized into contrast agent, imaging and others. The contrast agent segment is sub-segmented into iodine, gadolinium, and others. The imaging segment is sub-segmented into X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and others. On the basis of the application, the market is segmented into herniated discs, scoliosis, burst fracture, and others. On the basis of the indication, the market is segmented into spinal decompression, lumbar surgery, laminectomy, and others. On the basis of end user, the market is segmented into hospitals, retail pharmacies, academic institutes, others.
Regional Analysis
The Americas dominates the global discography market. Factors such as the presence of a well-developed healthcare sector, increasing prevalence of lower back pain, and rising healthcare expenditure provides the favorable backgrounds for the market growth within the region. Followed by Europe is the second large market for discography. Availability of funds for research, well developed healthcare infrastructure, huge patient population and government support for research & development are the major drivers for market growth in Europe. Asia Pacific is the fastest growing region for the market due to the presence of developing economies like India & China and favorable government policies. The Middle East & Africa has the least share in the global discography market due to presence of poor economies and stringent government policies within the region. Majority of the market of the Middle & Africa region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure by the presence of the economies like Saudi Arabia, Kuwait, and Qatar within the region.
Key Players
The key players for the global discography market are Stryker (U.S.), Johnson & Johnson Services, Inc. (U.S.), Merit Medical Systems, Inc. (U.S.), Medtronic (U.S.), GFS Chemicals, Inc. (U.S.), Avalon Advanced Materials (Canada), GE Healthcare (U.S.), Koninklijke Philips N.V. (the Netherlands), Canon Inc.  (Japan), Carestream Health. (U.S.), and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Monday, 13 January 2020

Europe Respiratory Therapeutic Devices Market Analysis and Industry Outlook to 2020


Europe Respiratory Therapeutic Devices Market – Overview:
Respiratory Therapeutic/ care devices are used for diagnosis, monitoring, and treatment of respiratory diseases such as COPD (chronic obstructive pulmonary disease), Chronic Bronchitis, Tuberculosis, Emphysema Asthma, and Pneumonia. These devices provide advanced care to patients suffering from severe and chronic respiratory diseases. Increasing prevalence of respiratory disorders & diseases in the region predominantly drives the market growth of Respiratory Therapeutic Devices in Europe.
Acknowledging the exponential growth the market perceives currently and gauging the potential the market holds to grow in the future; Market Research Future (MRFR), in its recently published market forecast asserts that the Europe Respiratory Therapeutic Devices Market will grow exponentially by 2020, registering a striking CAGR throughout the forecast period (2017 – 2020).

Major driving factors for the Europe respiratory caredevices market are the rise in the number of chronic pulmonary obstructive diseased patients, and the continuous surge in numbers due to changing lifestyle and environment such as increasing pollution level and smokers. Furthermore, rising geriatric population, the launching of the new product coupled with the robust pipeline of the product provide impetus to the market growth.
On the other hand, some of the harmful effects of respiratory devices and the low awareness in some of the developing regions are the factors affecting the market growth. Also, the excise tax on devices is expected to impact the market negatively in some countries.  
Europe Respiratory Therapeutic Devices Market – Segments
For the convenience of the report and enhanced understanding; MRFR has segmented the market into five key dynamics
By Products    : PAP Devices (CPAP Devices, APAP Devices, and BPAP Devices), Masks (Nasal Masks, Nasal Pillow Masks Full-Face Masks, and Oral Masks), Ventilators (Adult and Infant Ventilators), Nebulizers, Humidifiers (Heated and Passover Humidifiers), Oxygen Concentrators (Fixed and Portable Oxygen Concentrators), Inhalers (Dry Powder Inhalers and Metered Dose Inhalers), Resuscitators (Reusable and Disposable Resuscitators), Nitric Oxide Delivery Units, Oxygen Hoods, Others.
By Technology                   : Electrostatic Filtration, HEPA Filtration, Hollow Fiber Filtration, and Microsphere Separation among others.
By Applications : Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and others.
By Modes of Care: Hospital Care & Home Care among others
By Regions           : Europe - Germany, France, U.K., Italy, Spain, and Rest of Europe
Segment - Hospital Care by Modes of Care dominates the market, owing to the financial capabilities of hospitals to purchase high cost devices. 
Europe Respiratory Therapeutic Devices Market – Competitive Analysis
The Europe Respiratory Therapeutic Devices market is fiercely competitive with the presence of several large and small players operating in the market. These market players acquire promising companies to expand in the fast-growing markets, focusing on improving their market performance. The market structure is dynamic due to the acquisition of local manufactures by the multinational companies. Strategies like product innovations and technologies are creating strong investment opportunities for the market players.
Industry, Innovation & Related News
April 18, 2018 –INSYS Therapeutics, Inc. (US), a leading global players in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology announced its partnership with Senzer Ltd. (UK) to take the clinical research of dronabinol inhalation to the next level using a novel and patented breath-actuated device—licensed from Senzer and accepted by the FDA, U.S. under an IND (investigational new drug) filing, in the second half of 2018.
April 19, 2018 – ICON plc. (Ireland), a leading global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that it has reached a preliminary agreement with Intel to use the Intel Pharma Analytics Platform (AI-enabled remote monitoring) in clinical trials.
March 29, 2018 – Koninklijke Philips N.V. (The Netherlands) a leading global technology company focused in the area of healthcare, announced signing of a 15-Year Strategic Partnership Agreement with ZorgSaam (The Netherlands), a company offering hospital care, ambulance care, home care and elderly care to provide a wide range of integrated solutions for the diagnosis and treatment of patients.

Europe Respiratory Therapeutic Devices Market – Country-wise Analysis
Germany among the other European countries accounts for the leading market for Respiratory Therapeutic Devices, accounting for the largest revenue pocket, followed by the UK & France, respectively. The German market backed by the high expenditure on healthcare is the largest contributor to the Europe market growth. Moreover, increasing prevalence of respirational diseases & disorders coupled with the rising demand for treatment measures provides impetus to the market growth.
The UK stands the second-largest market in the Europe Respiratory Therapeutic Devices market. The strong market growth in the country drives the regional market growth, large scale, owing to the high per capita income and robust healthcare penetration in the country. Attributing to the increasing investment in healthcare and rising number of patients with respirational disorders & diseases, the UK market is projected to register a phenomenal CAGR during the forecast period.
France market for Respiratory Therapeutic Devices is expected to perceive an exponential growth, owing to the large patient pool and the burgeoning medical treatment market.      


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312


EMEA Surgical Equipment Market - Industry Forecast to 2023


Market Highlights

A surgical equipment is a designed tool or device to carry out various surgical procedures so as to modifying biological tissues and to provide access for viewing them. The surgical equipment can be designed specifically for a particular surgery or it can be used as general purpose equipment. Increasing global burden of the diseases like Parkinson’s disease, heart disease, cancer, and others followed by growing geriatric population and rising healthcare expenditures facilitates the market growth during the forecast period. In 2017, according to the World Health Organization, cancer was the second leading global cause of deaths, and was responsible for about 8.8 million deaths in 2015. Moreover, it was established that ~70% of the deaths due to cancer occur in low- and middle-income countries. However, high cost of the devices, shortage of skilled labor and strict regulatory policies are the major restraints for the market growth.

Segmentation

The EMEA surgical equipment market is segmented on the basis of product type, application, and end users.

On the basis of product type, the market is segmented into surgical sutures and staples, handheld surgical equipment, electrosurgical devices, electrosurgical devices, and others. The handheld surgical equipment segment is sub-segmented into forceps and spatulas, retractors, dilators, graspers, auxiliary instruments, cutter instruments, electrosurgical devices, and others. The auxiliary instrument sub-segment, by handheld surgical equipment segment, is further segmented into clamps, cannulas, closure devices, and others. The cutter instruments sub-segment, by handheld surgical equipment segment, is further segmented into trocars, lancets, scissors, and others. The electrosurgical devices segment is sub segmented into electro surgical generators, bipolar instruments, and monopolar instruments. The bipolar instruments sub-segment, by electrosurgical devices segment, is sub segmented into vessel sealing, forceps, and others. The monopolar instruments sub-segment, by electrosurgical devices segment, is further segmented into pencils, electrodes, and others. The bipolar instruments sub-segment, by electrosurgical devices segment, is sub segmented into vessel sealing, forceps, and others. The monopolar instruments sub-segment, by electrosurgical devices segment, is further segmented into pencils, electrodes, and others.

On the basis of application, the market is segmented into neurosurgery, obstetrics and gynecology, orthopedic surgery, cardiovascular surgery, and others.

On the basis of end users, the market is segmented into hospitals & clinics, research organization, academic institutes, and others.

Regional Analysis

Europe holds the largest share of EMEA surgical equipment market. Availability of funds for research, huge patient population and government support for research & development drives the European market. Moreover, presence of the developed economies like the Germany, and U.K. within the region fuels the market growth during the forecast period. According to the Macmillan Cancer Support in 2014, 357 million people in the U.K are diagnosed with cancer every year. Moreover, by 2020 it is estimated that almost one in two people (47%) will get cancer at some point in their lives.

On the other hand, the Middle East & Africa has the least share in the EMEA surgical equipment market due to presence of poor economy especially in Africa region. Majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

Key Players
Smith & Nephew (Europe), B. Braun Melsungen AG (Europe), Erbe Elektromedizin GmbH (Europe), Ethicon US, LLC. (U.S.), COVIDIEN. (Europe), CONMED Corporation. (U.S.), Integra LifeSciences Corporation. (U.S.), Valeant. (Canada), KLS Martin Group (Europe), and others.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Market Research Future
Office No. 524/528,
Amanora Chambers Magarpatta Road,
Hadapsar Pune - 411028
Maharashtra, India
+1 646 845 9312


Lung Function Tests Market Is Segmented On The Basis Of Type, Indication, Devices, And End User


Market Highlights
Lung function tests are a part of routine diagnostic tests recommended by the healthcare provider. These tests are used to diagnose number of respiratory diseases such as chronic obstructive pulmonary disease (COPD), and allergic conditions such as asthma. It comprises of tests such as spirometry, gas diffusion test, body plethysmography, bronchial provocation test, and others. Lung function tests also determine the whether the lungs are working properly, and their capacity to carry out respiration, thus making it necessary to identify the mode of treatment, and administration of drugs.

Prevalence of asthma is on the rise across the globe, especially in the developing countries.  The market is driven by the increasing prevalence of respiratory diseases in urban areas for developing countries and rising geriatric population. Additionally, increasing research and development activities, and technological advancements to identify the causes and risk factors for infectious lung diseases are fuelling the global lung function tests market growth.

The global lung function tests market is expected to grow at a CAGR of 5.7% during the forecast period.
Taste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Lung Function Tests market research report–Global forecast till 2023.”

Major Players in Lung Function Tests Market:
Some of the key players in the global market are CareFusion Corporation (U.S.), MGC Diagnostic Corporation (U.S.), General Electric Company (U.S.), Perkin Elmer (U.S., Carestream Health, Inc. (U.S.), COSMED srl (Italy), NIHON KOHDEN CORPORATION (Japan), and others.

Regional Analysis
The lung function tests market is growing at a rapid pace in the Americas owing to emphasis on healthy lifestyle, and prevention of lung diseases. Also, increasing demand for technologically advanced diagnostic devices and the presence of major market players adding fuel to the growth of the market.
In Europe, the prevalence of allergic conditions is high, especially asthma, and allergy rhinitis. Rising prevalence of allergic conditions, and extensive research and development activities on the medical devices drive the market growth.
In Asia Pacific, the increasing prevalence of asthma, chronic obstructive pulmonary disease, poor healthcare system, and availability of diagnostic services leads the market growth. According to the data from GLOBOCAN, in 2012, the age-standardized rate (ASR) of incidence of gastrointestinal diseases in Asia Pacific was 15.8 and mortality was 11.7 per 100,000 person. According to World Health Organization (WHO), the geriatric population in China in the year 2013 was 22.6 million which is expected to show a massive growth to 90.4 million in 2050.
In the Middle East & Africa, the demand for medical devices is increasing for the diagnosis of chronic diseases such as COPD and others. Rising awareness about lung diseases among the adults, and development of the healthcare sector in the African countries also drive the growth of the market.

Segmentation
The global lung function tests market is segmented on the basis of type, indication, devices, and end user.
On the basis of the type, the market is segmented into spirometry, gas diffusion test, body plethysmograph, bronchial provocation test, and others.
On the basis of the indication, the market is segmented into asthma, chronic bronchitis, respiratory infections, chronic obstructive pulmonary disease, cystic fibrosis, pneumonia, lung cancer, and others.
On the basis of the devices, the market is segmented into spirometer, breath CO monitor, oscillometer, ergospirometer, dose controlled drug nebulizer, and others.
On the basis of the end user, the market is segmented into hospitals, clinics, diagnostic centers, and others.


About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future:
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

North America is the largest market for Microfluidic Devices!!

Detail Analysis of Global Microfluidics Devices Market with respect to region specific market growth and competitive analysis on the basis of major players present in the market. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes America, Europe, Asia Pacific and Middle East and Africa. Forecast till 2023

The Microfluidics Devices Market is continually growing mainly due to the important role played by these devices in the integration, parallelization, and miniaturization of various tests in the fields of biological research, diagnostics, and drug development. Moreover, the widely accepted microfluidic technology that has several applications is accelerating the market on the global level, allowing integration of many medical tests on a single chip.
According to the recently published study report by Market Research Future (MRFR),   the global microfluidic device market is expected to touch a phenomenal valuation by 2024, registering a strong CAGR throughout the forecast period (2016-2024).


Additional factors positively impacting the growth of the market include the increasing prevalence of chronic diseases such as heart-related diseases and as cancer, prompting the demand for new drugs.  Microfluidics devices are becoming popular and are garnering tremendous traction, increasingly, attributing to their efficacy across the pharmaceutical and life science sector.
Resultantly, over the past couple of years, the microfluidic device market is increasingly accounting for a significant market share, worldwide. Vast advancements in technology and the huge uptake of these advanced technologies drive the growth of the microfluidic device market.
Additionally, factors such as the significantly increasing pharma industry and the increasing occurrences of lifestyle-related diseases and chronic diseases that require routine vital statistics analysis are propelling the market growth, augmenting the market demand for these devices.
Simultaneously, the increase in the analytical and commercial application of these devices and the use of microfluidic products for miniaturization of the chip such factors are driving market growth.
However, the stringent regulatory requirements to decelerate growth and geometrical and surface chemistry issues are some of the factors that are obstructing the growth of the market. On the other hand, factors like the growing R&D investment in life sciences and pharmaceuticals are increasing the demand and uptake of the point of care testing, as an effective method for delivery of treatment, are projected to escalate the market growth during the forecast period.
Major Players:
Fervent players leading the global microfluidic device market include Abbott Laboratories, F Hoffmann-La Roche AG, Siemens Healthcare GMBH, Agilent Technologies, Inc., Fluidigm Corporation, Bio-Rad Laboratories, Inc, Dolomite Centre, Cepheid, Raindance Technologies, Inc., Johnson & Johnson, Micronit Microfluidics, and Becton, Dickinson & Company among others.
Industry/ Innovation/ Related News:
February 28, 2019 --- A research team from the biomedical engineering dept., The University of California announced the development of a new wearable respiratory sensor using a microfluidic chip to monitor children with chronic pulmonary conditions. This new bio-wearable respiratory device will allow doctors an accurate, fast, and affordable method to monitor children with chronic pulmonary conditions.
February 14, 2019 --- A team of researchers from the Singapore University of Technology and Design (SUTD) announced the development of a customizable microfluidic system that can generate complex dispersions of liquid droplets that are otherwise known as emulsions as they are not soluble in another liquid. This is a single device consisting of a 3D-printed connector and a needle secured by elastic tubes and aligned to a common axis.
Global Microfluidics Device Market – Segments
MRFR has segmented the analysis into four key dynamics for enhanced understanding
By Application: Drug Delivery, Pharmaceutical, Analytical Device, Environmental & Industrial, and Life Science Research among others.
By Industry: Microfluidic Devices, Microfluidics, and others.
By Material: Polymer, Glass, Silicon, and others.
By Regions: Asia Pacific, Europe, North America, and the Rest-of-the-World
Global Microfluidics Device Market – Regional Analysis
North America heading with its one of the world's best medical facilities, dominates the global microfluidics devices market. The US, led by the huge technological advancements and high per capita healthcare expenditures accounts for the leading market for the microfluidic devices in the region.
Some of the factors such as the availability of technologically advanced medical devices, the presence of well-established healthcare infrastructure, and skilled professionals are positively impacting the growth in the regional market. 
The microfluidic device market in the European region accounts for the second-largest market, globally.  Factors such as the resurging economy that is availing the best possible healthcare, increasing healthcare expenditures, substantially, and the government support that encourages manufacturers of microfluidics devices to develop new and better devices are propelling the growth of the regional market.
The Asia Pacific microfluidics devices market is emerging as a profitable market mainly due to the rapidly improving healthcare infrastructure. Moreover, factors positively impacting the growth in the regional market include the rapidly increasing population that is dictating the demand for quality healthcare, continually and the spreading awareness towards the availability and benefits of these devices. Rapidly developing economies are providing immense opportunities in the microfluidics devices market in the region.
Besides, the increasing adoption of technologies is impacting market growth in the region, positively. Furthermore, growing healthcare concerns are increasing the market size of the microfluidic device market.
Global Microfluidics Device Market – Competitive Analysis
Fiercely competitive, the microfluidics market is well-established with the presence of several large and small-scale players. These players incorporate strategic initiatives such as collaboration, acquisition, expansion, product & technology, and partnership to gain a competitive edge and to maintain their market positions. They invest substantially in R&D to develop advanced systems.
High growth opportunities that the market demonstrates are in turn, intensifying the competition in the already highly competitive market, attracting several new entrants to the market, further.
Manufacturers of microfluidics devices invest R&D activities substantially to develop advent technology and to acquire promising firms in the rapidly developing regions to meet their expansion plan. The rising government funding is motivating key companies to manufacture innovative devices that can match the changing trends and needs of the customers.

Browse Complete 90 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/microfluidics-device-market-684
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312